MIF Metastasis/MDSC-inducing factor?

OncoImmunology

Volumn 2, Issue 3, 2013, Pages

  Simpson, Kendra D ^a   Cross, Janet V ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

MDSC; Metastasis; MIF; Sulforaphane; Tautomerase; Tumor microenvironment

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; IMMUNE DEFICIENCY; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT;

EID: 84886944773     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23337     Document Type: Article

References (10)

1. Zhe X, Cher ML, Bonfil RD. Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 2011; 1:740-51; PMID:22016824.
2. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71-8; PMID:14708027; http://dx.doi.org/10.1038/nrc1256.
3. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506.
4. Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 2010; 59:1593-600; PMID:20414655; http://dx.doi.org/10.1007/s00262-010-0855-8.
5. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010; 22:238-44; PMID:20171075; http://dx.doi.org/10.1016/j.coi.2010.01.021.
6. Montero AJ, Diaz-Montero CM, Kyriakopoulos CE, Bronte V, Mandruzzato S. Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J Immunother 2012; 35:107-15; PMID:22306898; http://dx.doi.org/10.1097/CJI.0b013e318242169f.
7. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010; 23:257-64; PMID:20520854; http://dx.doi.org/10.1358/dnp.2010.23.4.1453629.
8. Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, Templeton DJ. Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem J 2009; 423:315-21; PMID:19723024; http://dx.doi.org/10.1042/BJ20091170.
9. Mitchell RA, Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 2000; 10:359-66; PMID:11100884; http://dx.doi.org/10.1006/scbi.2000.0328.
10. Simpson KD, Templeton DJ, Cross JV. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. J Immunol 2012; 189:5533-40; PMID:23125418; http://dx.doi.org/10.4049/jimmunol.1201161.